Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I PCF chemoradiotherapy for esophageal cancer
jRCTs051180082Phase 1Active, not recruiting
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of paclitaxel, cisplatin and fluorouracil in esophageal cancer. Primary endpoint: Dose-limiting toxicity (DLT) occurrence rate at each dose level. Started Jul 2017; status: active, not recruiting.
02
Drugs
paclitaxelcisplatinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs051180082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180082.